Gastric damage and granulocyte infiltration induced by indomethacin in tumour factor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice

Gut

Volumn 53, Issue 6, 2004, Pages 791-796

  Souza, M H L P ^a,b   Paula Lemos, H ^b   Oliveira, R B ^b   Cunha, F Q ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FUCOIDIN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; THALIDOMIDE; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME INHIBITION; EVALUATION; GENETICS; GRANULOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STOMACH DISEASE; STOMACH EROSION; STOMACH INJURY; TIME; WILD TYPE;

AMIDINES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZYLAMINES; ENZYME INHIBITORS; GASTRIC MUCOSA; GRANULOCYTES; INDOMETHACIN; MICE; MICE, INBRED C57BL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, TUMOR NECROSIS FACTOR; STOMACH DISEASES;

EID: 2442686478     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2002.012930     Document Type: Article

References (37)

1. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001;120:594-606.
2. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990;259:G462-7.
3. Trevethick MA, Clayton NM, Strang P, et al. Do infiltrating neutrophils contribute to the pathogenesis of indomethacin induced ulceration of the rat gastric antrum? Gut 1993;34:156-60.
4. Santucci L, Fiorucci S, Di Matteo FM, et al. Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology 1995;1108:393-401.
5. Appleyard CB, McCafferty DM, Tigley AW, et al. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol 1996;270:G42-8.
6. Morise Z, Granger DN, Fuseler JW, et al. Indomethacin induced gastropathy in CD18, intercellular adhesion molecule 1, or P-selectin deficient mice. Gut 1999;45:523-8.
7. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992;13:151-3.
8. Muscara MN, Wallace JL. Nitric oxide. V. therapeutic potential of nitric oxide donors and inhibitors. Am J Physiol 1999;276:G1313-16.
9. Wallace JL, Miller MJ. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 2000;119:512-20.
10. Piotrowski J, Slomiany A, Slomiany BL. Activation of apoptotic caspase-3 and nitric oxide synthase-2 in gastric mucosal injury induced by indomethacin. Scand J Gastroenterol 1999;34:129-34.
11. Pfeffer K, Matsuyama T, Kundig TM, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L monocytogenes infection. Cell 1993;73:457-67.
12. Varki A. Selectin ligands. Proc Natl Acad Sci U S A 1994;91:7390-7.
13. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.
14. Santucci L, Fiorucci S, Giansanti M, et al. Pentoxifylline prevents indomethacin-induced acute gastric-mucosal damage in rats - role of tumor-necrosis-factor-alpha. Gut 1994;35:909-15.
15. Souza DG, Cassali GD, Poole S, et al. Effects of inhibition of PDE4 and TNF-α on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol 2001;134:985-94.
16. Sampaio EP, Sarno EN, Galilly R, et al. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991;173:699-703.
17. Garvey EP, Oplinger JA, Furfine ES, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997;272:4959-63.
18. Bradley PP, Christensen RD, Rothstein G. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 1982;3:618-22.
19. Wallace JL, McKnight W, Miyasaka M, et al. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am J Physiol 1993;265:G993-8.
20. Schmid RM, Adler G. NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases. Gastroenterology 2000;118:1208-28.
21. Haynes RC. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Gilman AG, Rall TW, Nies AS, et al, eds. The pharmacological basis of therapeutics, 8th edn. New York: Pergamon Press, 1990:1431-62.
22. Wallace JL, Ma L. Inflammatory mediators in gastrointestinal defense and injury. Exp Biol Med (Maywood) 2001;226:1003-15.
23. Yasuhiro T, Korolkiewicz RP, Kato S, et al. Role of nitric oxide in pathogenesis of serotonin-induced gastric lesions in rats. Pharmacol Res 1997;36:333-8.
24. Yasuhiro T, Konaka A, Kato S, et al. Gastric mucosal damage induced by compound 48/80: roles of serotonin and nitric oxide. J Gastroenterol Hepatol 1998;13:1099-106.
25. Nishida K, Ohta Y, Ishiguro I. Relation of inducible nitric oxide synthase activity to lipid peroxidation and nonprotein sulfhydryl oxidation in the development of stress-induced gastric mucosal lesions in rats. Nitric Oxide 1998;2:215-23.
26. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrolyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996;56:3238-43.
27. Calatayud S, Sanz MJ, Canet A, et al. Mechanisms of gastroprotection by transdermal nitroglycerin in the rat. Br J Pharmacol 1999;127:1111-18.
28. Elliott SN, McKnight W, Cirino G, et al. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995;109:524-30.
29. Lamarque D, Whittle BJ. Role of oxygen-derived metabolites in the rat gastric mucosal injury induced by nitric oxide donors. Eur J Pharmacol 1995;277:187-94.
30. Gurbuz V, Alican I, Berrak, et al. Role of nitric oxide in indomethacin-induced gastric mucosal dysfunction in the rat. Exp Physiol 1999;84:319-32.
31. Khattab MM, Gad MZ, Abdallah D. Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion. Pharmacol Res 2001;43:463-7.
32. Ferraz JG, Tigley A, Wallace JL. Paradoxical effects of L-arginine on gastric mucosal integrity. Eur J Pharmacol 1994;260:107-11.
33. Ma L, Wallace JL. Endothelial nitric oxide synthase modulates gastric ulcer healing in rats. Am J Physiol Gastrointest Liver Physiol 2000;279:G341-6.
34. Ferraz JG, Sharkey KA, Reuter BK, et al. Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. Gastroenterology 1997;113:195-204.
35. Fox-Robichaud A, Payne D, Kubes P. Inhaled NO reaches distal vasculatures to inhibit endothelium- but not leukocyte-dependent cell adhesion. Am J Physiol 1999;277:L1224-31.
36. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991;88:4651-5.
37. Benjamim CF, Silva JS, Fortes ZB, et al. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect Immun 2002;70:3602-10.